Point72 Asset Management
KURA icon

Point72 Asset Management’s Kura Oncology KURA Stock Holding History

Point72 Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-189,103
Closed -$3.7M – 2264
2024
Q3 		$3.7M Buy
+189,103
New +$3.83M 0.01% 967
2023
Q2 		– Sell
-11,428
Closed -$140K – 2490
2023
Q1 		$140K Buy
+11,428
New +$143K ﹤0.01% 1567
2020
Q4 		– Sell
-159,936
Closed -$4.9M – 1034
2020
Q3 		$4.9M Sell
159,936
-18,164
-10% -$401K 0.03% 568
2020
Q2 		$2.9M Buy
+178,100
New +$2.57M 0.02% 550
2020
Q1 		– Sell
-159,612
Closed -$2.19M – 940
2019
Q4 		$2.19M Buy
+159,612
New +$2.37M 0.01% 618
2018
Q4 		– Sell
-377,952
Closed -$6.61M – 1096
2018
Q3 		$6.61M Buy
377,952
+245,406
+185% +$4.7M 0.03% 539
2018
Q2 		$2.41M Buy
+132,546
New +$2.24M 0.01% 734
2018
Q1 		– Sell
-173,200
Closed -$2.65M – 1037
2017
Q4 		$2.65M Buy
+173,200
New +$2.55M 0.01% 695

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management's KURA Position: Q4 2024 in Review

Point72 Asset Management sold out of Kura Oncology (KURA) in Q4 2024, closing a stake of 189,103 shares — an estimated $3.7M sold.

Point72 Asset Management first reported a position in KURA in Q4 2017 and held it in 8 quarters. The position peaked at $6.61M in Q3 2018. 185 funds tracked by Wall St. Rank hold KURA as of Q4 2024.

  • Point72 Asset Management reported no remaining Kura Oncology position as of Q4 2024 after selling out during the quarter.
  • Point72 Asset Management sold 189,103 Kura Oncology shares in Q4 2024, an estimated $3.7M.
  • Point72 Asset Management first reported a position in Kura Oncology in Q4 2017 and held it in 8 quarters.
  • Point72 Asset Management's Kura Oncology position peaked at $6.61M in Q3 2018.
  • 185 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2024.

Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.